Cargando…

PB2141: CLINICOPATHOLOGICAL FEATURES AND OUTCOME OF CD5 POSITIVE DIFFUSE LARGE B CELL LYMPHOMA AND THE SIGNIFICANCE OF CD5 EXPRESSION STRENGTH: 10-YEAR SINGLE CENTER EXPERIENCE

Detalles Bibliográficos
Autores principales: Vukovic, V., Karan-Djurasevic, T., Otasevic, V., Sarac, S., Sabljic, N., Antic, D., Djurasinovic, V., Tomic, K., Mihaljevic, B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429660/
http://dx.doi.org/10.1097/01.HS9.0000851396.39065.72
_version_ 1784779525637275648
author Vukovic, V.
Karan-Djurasevic, T.
Otasevic, V.
Sarac, S.
Sabljic, N.
Antic, D.
Djurasinovic, V.
Tomic, K.
Mihaljevic, B.
author_facet Vukovic, V.
Karan-Djurasevic, T.
Otasevic, V.
Sarac, S.
Sabljic, N.
Antic, D.
Djurasinovic, V.
Tomic, K.
Mihaljevic, B.
author_sort Vukovic, V.
collection PubMed
description
format Online
Article
Text
id pubmed-9429660
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94296602022-08-31 PB2141: CLINICOPATHOLOGICAL FEATURES AND OUTCOME OF CD5 POSITIVE DIFFUSE LARGE B CELL LYMPHOMA AND THE SIGNIFICANCE OF CD5 EXPRESSION STRENGTH: 10-YEAR SINGLE CENTER EXPERIENCE Vukovic, V. Karan-Djurasevic, T. Otasevic, V. Sarac, S. Sabljic, N. Antic, D. Djurasinovic, V. Tomic, K. Mihaljevic, B. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429660/ http://dx.doi.org/10.1097/01.HS9.0000851396.39065.72 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Vukovic, V.
Karan-Djurasevic, T.
Otasevic, V.
Sarac, S.
Sabljic, N.
Antic, D.
Djurasinovic, V.
Tomic, K.
Mihaljevic, B.
PB2141: CLINICOPATHOLOGICAL FEATURES AND OUTCOME OF CD5 POSITIVE DIFFUSE LARGE B CELL LYMPHOMA AND THE SIGNIFICANCE OF CD5 EXPRESSION STRENGTH: 10-YEAR SINGLE CENTER EXPERIENCE
title PB2141: CLINICOPATHOLOGICAL FEATURES AND OUTCOME OF CD5 POSITIVE DIFFUSE LARGE B CELL LYMPHOMA AND THE SIGNIFICANCE OF CD5 EXPRESSION STRENGTH: 10-YEAR SINGLE CENTER EXPERIENCE
title_full PB2141: CLINICOPATHOLOGICAL FEATURES AND OUTCOME OF CD5 POSITIVE DIFFUSE LARGE B CELL LYMPHOMA AND THE SIGNIFICANCE OF CD5 EXPRESSION STRENGTH: 10-YEAR SINGLE CENTER EXPERIENCE
title_fullStr PB2141: CLINICOPATHOLOGICAL FEATURES AND OUTCOME OF CD5 POSITIVE DIFFUSE LARGE B CELL LYMPHOMA AND THE SIGNIFICANCE OF CD5 EXPRESSION STRENGTH: 10-YEAR SINGLE CENTER EXPERIENCE
title_full_unstemmed PB2141: CLINICOPATHOLOGICAL FEATURES AND OUTCOME OF CD5 POSITIVE DIFFUSE LARGE B CELL LYMPHOMA AND THE SIGNIFICANCE OF CD5 EXPRESSION STRENGTH: 10-YEAR SINGLE CENTER EXPERIENCE
title_short PB2141: CLINICOPATHOLOGICAL FEATURES AND OUTCOME OF CD5 POSITIVE DIFFUSE LARGE B CELL LYMPHOMA AND THE SIGNIFICANCE OF CD5 EXPRESSION STRENGTH: 10-YEAR SINGLE CENTER EXPERIENCE
title_sort pb2141: clinicopathological features and outcome of cd5 positive diffuse large b cell lymphoma and the significance of cd5 expression strength: 10-year single center experience
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429660/
http://dx.doi.org/10.1097/01.HS9.0000851396.39065.72
work_keys_str_mv AT vukovicv pb2141clinicopathologicalfeaturesandoutcomeofcd5positivediffuselargebcelllymphomaandthesignificanceofcd5expressionstrength10yearsinglecenterexperience
AT karandjurasevict pb2141clinicopathologicalfeaturesandoutcomeofcd5positivediffuselargebcelllymphomaandthesignificanceofcd5expressionstrength10yearsinglecenterexperience
AT otasevicv pb2141clinicopathologicalfeaturesandoutcomeofcd5positivediffuselargebcelllymphomaandthesignificanceofcd5expressionstrength10yearsinglecenterexperience
AT saracs pb2141clinicopathologicalfeaturesandoutcomeofcd5positivediffuselargebcelllymphomaandthesignificanceofcd5expressionstrength10yearsinglecenterexperience
AT sabljicn pb2141clinicopathologicalfeaturesandoutcomeofcd5positivediffuselargebcelllymphomaandthesignificanceofcd5expressionstrength10yearsinglecenterexperience
AT anticd pb2141clinicopathologicalfeaturesandoutcomeofcd5positivediffuselargebcelllymphomaandthesignificanceofcd5expressionstrength10yearsinglecenterexperience
AT djurasinovicv pb2141clinicopathologicalfeaturesandoutcomeofcd5positivediffuselargebcelllymphomaandthesignificanceofcd5expressionstrength10yearsinglecenterexperience
AT tomick pb2141clinicopathologicalfeaturesandoutcomeofcd5positivediffuselargebcelllymphomaandthesignificanceofcd5expressionstrength10yearsinglecenterexperience
AT mihaljevicb pb2141clinicopathologicalfeaturesandoutcomeofcd5positivediffuselargebcelllymphomaandthesignificanceofcd5expressionstrength10yearsinglecenterexperience